Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000950170-25-018887

President and CEO gave up 12,547 shares (to pay taxes)

  • President and CEO acquired 31,249 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Culley Brian M · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-11 Exercise or conversion : show line 1 in the form +31,249 226,091 D
2025-02-11 Shares withheld for taxes : show line 2 in the form −12,547 $0.65 $8,156 213,544 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-11 Exercise or conversion : show line 3 in the form Restricted Stock Units −31,249 31,250 D
Loading xslF345X05/ownership.xml…